Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

According to Research by SNS Insider, Global Prostate Cancer Diagnostics Market Growth is Fueled by Growing Demand for Advanced Biomarker Testing, AI Diagnostics, and Outpatient Screening Services ...

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

As many men delay seeing a doctor out of embarrassment, a number of non-invasive tests for prostate and testicular cancer are on the horizon that are even more accurate in detecting the disease in ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

Mr Bailey said a recent prostate cancer death prompted him to get tested. Inviting the Mail as he underwent a PSA test, the Zambia-born former RAF wing commander said: 'I think sadly, with the ...

Because of the large impact of prostate cancer, there is great interest in new methods of prevention and treatment; some of these appear to reduce mortality. [4] Lycopene is a natural product that ...